Skip to main content

Advertisement

Peer Review reports

From: A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis

Original Submission
9 Jan 2018 Submitted Original manuscript
8 Feb 2018 Reviewed Reviewer Report - Tracy Frech
13 Mar 2018 Reviewed Reviewer Report - John Pauling
21 Mar 2018 Author responded Author comments - Annemarie Schorpion
Resubmission - Version 2
21 Mar 2018 Submitted Manuscript version 2
10 Apr 2018 Author responded Author comments - Annemarie Schorpion
Resubmission - Version 3
10 Apr 2018 Submitted Manuscript version 3
Publishing
24 Apr 2018 Editorially accepted
15 May 2018 Article published 10.1186/s41927-018-0021-z

You can find further information about peer review here.

Back to article page